• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Thoratec Corporation THORATEC® HEARTMATE®, LVAS IMPLANT KIT (WITH SEALED GRAFTS); Ventricular (Assist) Bypass

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Thoratec Corporation THORATEC® HEARTMATE®, LVAS IMPLANT KIT (WITH SEALED GRAFTS); Ventricular (Assist) Bypass Back to Search Results
Model Number 106015
Medical Device Problem Codes Mechanical Problem (1384); Infusion or Flow Problem (2964)
Health Effect - Clinical Codes Obstruction/Occlusion (2422); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/07/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the log files were submitted to evaluate power spikes.It appeared there were no unusual events recorded in the log file event history.The mechanical circulatory support (mcs) equipment was operating as intended.The pump parameters trending showed power and flow trending upward with pulsatility index (pi) trending downward slightly.Per technical services, this trending could be suspect of pump thrombus.On (b)(6) 2026, the patient was admitted for elevated flows and powers (>8).Computed tomography (ct) showed narrowing of outflow graft.Upon inspection in the cardiac catheterization laboratory, narrowing and gradient were not substantial enough for team to stent the graft.During the procedure, flows and powers returned to normal, with flows in the 4 liter per minute range (lpm) and powers in 6's.Additional log files sent for review revealed that the power went down from 8.6 watts (w) to 6.1w and estimated flow from 8.6lpm to 4.5lpm on 14 jul 2026 at 15:13.Otherwise, there were no other notable alarm conditions or parameter changes in the log file.The ventricular assist device (vad) was functioning as intended.
 
Additional Manufacturer Narrative
No further information was provided.A supplemental report will be reported once the manufacturer¿s investigation is completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THORATEC® HEARTMATE®, LVAS IMPLANT KIT (WITH SEALED GRAFTS)
Common Device Name
Ventricular (Assist) Bypass
Manufacturer (Section D)
Thoratec Corporation
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
Thoratec Corporation
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
fredric gold
6035 stoneridge drive
pleasanton, CA 94588
+1(781)852-8207
MDR Report Key50099844
Report Number2916596-2026-2918655
Device Sequence Number10479204
Product Code DSQ
UDI-Device Identifier00813024011224
UDI-Public(01)00813024011224
Combination Product (Y/N)N
Initial Reporter StateDC
Initial Reporter CountryUS
PMA/510(K) Number
P060040
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/13/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model Number106015
Device Catalogue Number106015
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/07/2026
Supplement Date Received by Manufacturer08/11/2026
Initial Report FDA Received Date07/31/2026
Supplement Report FDA Received Date08/13/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age70 YR
Patient SexFemale
-
-